Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Michalek

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|August 15, 1981
Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibodyC K Grant, M T Michalek
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processingM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Effect of gangliosides on activation of the alternative pathway of human complementM T Michalek, E G Bremer, C Mold
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Inhibition of the alternative pathway of human complement by structural analogues of sialic acidM T Michalek, C Mold, E G Bremer
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shockM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
Weak base amines can inhibit class I MHC-restricted antigen presentationM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentationM T Michalek, E P Grant, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentationE P Grant, M T Michalek, A L Goldberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1990
Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutantsL H Dang, M T Michalek, F Takei, et al.
Journal of the National Cancer Institute|December 1, 1980
Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cellsC K Grant, F de Noronha, C Tusch, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|August 15, 1981
Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibodyC K Grant, M T Michalek
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processingM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Effect of gangliosides on activation of the alternative pathway of human complementM T Michalek, E G Bremer, C Mold
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Inhibition of the alternative pathway of human complement by structural analogues of sialic acidM T Michalek, C Mold, E G Bremer
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shockM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
Weak base amines can inhibit class I MHC-restricted antigen presentationM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentationM T Michalek, E P Grant, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentationE P Grant, M T Michalek, A L Goldberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1990
Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutantsL H Dang, M T Michalek, F Takei, et al.
Journal of the National Cancer Institute|December 1, 1980
Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cellsC K Grant, F de Noronha, C Tusch, et al.
Pageof 2